Compare, Analyse Torrent Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs MYLAN (US) - Comparison Results

TORRENT PHARMA     Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   MYLAN
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-19
MYLAN
Dec-18
TORRENT PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,9643,554-   
Low Rs1,2451,956-   
Sales per share (Unadj.) Rs453.41,635.5-  
Earnings per share (Unadj.) Rs25.844.4-  
Cash flow per share (Unadj.) Rs62.3350.6-  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs279.21,769.3-  
Shares outstanding (eoy) m169.22514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.51.7 210.0%   
Avg P/E ratio x62.262.0 100.3%  
P/CF ratio (eoy) x25.87.9 327.8%  
Price / Book Value ratio x5.71.6 369.0%  
Dividend payout %65.90-   
Avg Mkt Cap Rs m271,5131,417,614 19.2%   
No. of employees `00013.635.0 38.9%   
Total wages/salary Rs m14,0380-   
Avg. sales/employee Rs Th5,642.624,041.6 23.5%   
Avg. wages/employee Rs Th1,032.40-   
Avg. net profit/employee Rs Th320.9652.8 49.1%   
INCOME DATA
Net Sales Rs m76,728841,456 9.1%  
Other income Rs m5710-   
Total revenues Rs m77,299841,456 9.2%   
Gross profit Rs m19,831217,738 9.1%  
Depreciation Rs m6,177157,554 3.9%   
Interest Rs m5,03840,471 12.4%   
Profit before tax Rs m9,18719,713 46.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5700-   
Tax Rs m1,254-3,136 -40.0%   
Profit after tax Rs m4,36322,849 19.1%  
Gross profit margin %25.825.9 99.9%  
Effective tax rate %13.6-15.9 -85.8%   
Net profit margin %5.72.7 209.4%  
BALANCE SHEET DATA
Current assets Rs m50,375469,868 10.7%   
Current liabilities Rs m51,653342,586 15.1%   
Net working cap to sales %-1.715.1 -11.0%  
Current ratio x1.01.4 71.1%  
Inventory Days Days9284 110.2%  
Debtors Days Days6893 73.2%  
Net fixed assets Rs m83,648163,229 51.2%   
Share capital Rs m846448 188.9%   
"Free" reserves Rs m46,3970-   
Net worth Rs m47,244910,302 5.2%   
Long term debt Rs m39,129982,508 4.0%   
Total assets Rs m141,2092,441,784 5.8%  
Interest coverage x2.81.5 189.9%   
Debt to equity ratio x0.81.1 76.7%  
Sales to assets ratio x0.50.3 157.7%   
Return on assets %6.72.6 256.7%  
Return on equity %9.22.5 367.9%  
Return on capital %12.33.2 387.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m16,5810-   
CASH FLOW
From Operations Rs m17,981174,855 10.3%  
From Investments Rs m-2,413-90,381 2.7%  
From Financial Activity Rs m-13,145-81,458 16.1%  
Net Cashflow Rs m2,3801,449 164.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 74.67 Rs / USD

Compare TORRENT PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: IPCA LABS  DIVIS LABORATORIES  ALEMBIC PHARMA  GLENMARK PHARMA  NEULAND LABS  



Today's Market

Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views On News

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

A Critical Update on the Market (Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy (Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers (Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

India's Revival: A Once-in-a-generation Wealth Making Opportunity
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

TORRENT PHARMA SHARE PRICE


Apr 9, 2021 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

FEATURED VIDEOS

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

Kalyan Jewellers IPO: An Honest View

More Featured Videos

MARKET STATS